119 related articles for article (PubMed ID: 38253492)
1. Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Radhakrishnan A; Subramanian L; Rankin AJ; Fetters MD; Wittmann DA; Ginsburg KB; Hawley ST; Skolarus TA
Ann Fam Med; 2024; 22(1):5-11. PubMed ID: 38253492
[TBL] [Abstract][Full Text] [Related]
2. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
[TBL] [Abstract][Full Text] [Related]
3. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.
Radhakrishnan A; Wallner LP; Skolarus TA; George AK; Rosenberg BH; Abrahamse P; Hawley ST
J Urol; 2022 Sep; 208(3):600-608. PubMed ID: 35522191
[TBL] [Abstract][Full Text] [Related]
4. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
[TBL] [Abstract][Full Text] [Related]
5. How Men with Prostate Cancer Choose Specialists: A Qualitative Study.
Jiang T; Stillson CH; Pollack CE; Crossette L; Ross M; Radhakrishnan A; Grande D
J Am Board Fam Med; 2017; 30(2):220-229. PubMed ID: 28379829
[TBL] [Abstract][Full Text] [Related]
6. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
[TBL] [Abstract][Full Text] [Related]
7. Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration.
Radhakrishnan A; Henry J; Zhu K; Hawley ST; Hollenbeck BK; Hofer T; Wittmann DA; Sales AE; Skolarus TA
Cancer Med; 2019 May; 8(5):2686-2702. PubMed ID: 30950216
[TBL] [Abstract][Full Text] [Related]
8. Factors for Supporting Primary Care Physician Engagement With Patient Apps for Type 2 Diabetes Self-Management That Link to Primary Care: Interview Study.
Ayre J; Bonner C; Bramwell S; McClelland S; Jayaballa R; Maberly G; McCaffery K
JMIR Mhealth Uhealth; 2019 Jan; 7(1):e11885. PubMed ID: 30664468
[TBL] [Abstract][Full Text] [Related]
9. Factors that influence clinicians' decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study.
Lowenstein LM; Choi NJ; Hoffman KE; Volk RJ; Loeb S
BMJ Open; 2021 Nov; 11(11):e048347. PubMed ID: 34772748
[TBL] [Abstract][Full Text] [Related]
10. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
11. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
12. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.
Wade J; Holding PN; Bonnington S; Rooshenas L; Lane JA; Salter CE; Tilling K; Speakman MJ; Brewster SF; Evans S; Neal DE; Hamdy FC; Donovan JL;
BMJ Open; 2015 Sep; 5(9):e008953. PubMed ID: 26384727
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.
Makarov DV; Sedlander E; Braithwaite RS; Sherman SE; Zeliadt S; Gross CP; Curnyn C; Shedlin M
Implement Sci; 2016 Sep; 11(1):118. PubMed ID: 27590603
[TBL] [Abstract][Full Text] [Related]
14. Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions.
Radhakrishnan A; Wallner LP; Skolarus TA; Abrahamse PH; Kollipara AS; Katz SJ; Hawley ST
J Gen Intern Med; 2021 Feb; 36(2):447-454. PubMed ID: 33123958
[TBL] [Abstract][Full Text] [Related]
15. Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G; De Luca S; Oderda M; Munoz F; Krengli M; Allis S; Baima CG; Barale M; Bartoncini S; Beldì D; Bellei L; Bellissimo AR; Bernardi D; Biamino G; Billia M; Borsa R; Cante D; Castelli E; Cattaneo G; Centrella D; Collura D; Coppola P; Dalmasso E; Di Stasio A; Fasolis G; Fiorio M; Garibaldi E; Girelli G; Griffa D; Guercio S; Migliari R; Molinaro L; Montefiore F; Montefusco G; Moroni M; Muto G; Ponti di Sant'Angelo F; Ruggiero L; Ruo Redda MG; Serao A; Squeo MS; Stancati S; Surleti D; Varvello F; Volpe A; Zaramella S; Zarrelli G; Zitella A; Bollito E; Gontero P; Porpiglia F; Galassi C; Bertetto O;
JAMA Netw Open; 2023 Oct; 6(10):e2338039. PubMed ID: 37847502
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
17. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
18. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
[TBL] [Abstract][Full Text] [Related]
19. Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40-49.
Nadler MB; Corrado AM; Wilson BE; Desnoyers A; Amir E; Ivers N; Desveaux L
BMC Womens Health; 2023 Feb; 23(1):75. PubMed ID: 36803461
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil.
Wroclawski ML; Amaral BS; Kayano PP; Busato WFS; Westphal SJ; Montagna E; Bianco B; Soares A; Maluf FC; Lemos GC; Carneiro A
BMC Urol; 2022 Jun; 22(1):86. PubMed ID: 35706024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]